Oncternal Therapeutics Stock Technical Analysis
| ONCT Stock | USD 0.71 0.43 37.72% |
As of the 26th of November, Oncternal Therapeutics holds the Risk Adjusted Performance of (0.09), coefficient of variation of (812.74), and Variance of 127.32. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncternal Therapeutics, as well as the relationship between them.
Oncternal Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Oncternal, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OncternalOncternal |
Oncternal Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 1.93 | Hold | 2 | Odds |
Most Oncternal analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Oncternal stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Oncternal Therapeutics, talking to its executives and customers, or listening to Oncternal conference calls.
Oncternal Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Oncternal Therapeutics Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Oncternal Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Oncternal Therapeutics Trend Analysis
Use this graph to draw trend lines for Oncternal Therapeutics. You can use it to identify possible trend reversals for Oncternal Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Oncternal Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Oncternal Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Oncternal Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that Oncternal Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 44.72, which is the sum of squared deviations for the predicted Oncternal Therapeutics price change compared to its average price change.About Oncternal Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Oncternal Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Oncternal Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Oncternal Therapeutics price pattern first instead of the macroeconomic environment surrounding Oncternal Therapeutics. By analyzing Oncternal Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Oncternal Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Oncternal Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 (projected) | Graham Number | 149.5 | 55.57 | 52.79 | Receivables Turnover | 8.37 | 1.24 | 1.18 |
Oncternal Therapeutics November 26, 2024 Technical Indicators
Most technical analysis of Oncternal help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oncternal from various momentum indicators to cycle indicators. When you analyze Oncternal charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 2.47 | |||
| Mean Deviation | 6.1 | |||
| Coefficient Of Variation | (812.74) | |||
| Standard Deviation | 11.28 | |||
| Variance | 127.32 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (1.33) | |||
| Total Risk Alpha | (3.18) | |||
| Treynor Ratio | 2.46 | |||
| Maximum Drawdown | 65.49 | |||
| Value At Risk | (14.12) | |||
| Potential Upside | 11.49 | |||
| Skewness | (1.02) | |||
| Kurtosis | 13.9 |
Oncternal Therapeutics November 26, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Oncternal stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 208,544 | ||
| Daily Balance Of Power | (1.95) | ||
| Rate Of Daily Change | 0.62 | ||
| Day Median Price | 0.73 | ||
| Day Typical Price | 0.72 | ||
| Price Action Indicator | (0.23) |
Additional Tools for Oncternal Stock Analysis
When running Oncternal Therapeutics' price analysis, check to measure Oncternal Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncternal Therapeutics is operating at the current time. Most of Oncternal Therapeutics' value examination focuses on studying past and present price action to predict the probability of Oncternal Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncternal Therapeutics' price. Additionally, you may evaluate how the addition of Oncternal Therapeutics to your portfolios can decrease your overall portfolio volatility.